Yüksek Akışlı Nazal Kanül Oksijenizasyon Tedavisinin Yoğun Bakım Ünitesi ve Ameliyathanede Kullanımı
Özet
Yüksek Akışlı Nazal Kanül (YANKO) tedavisi, ısıtılmış ve nemlendirilmiş oksijeni yüksek akım hızlarında (20-60 L/dk) sunan invaziv olmayan bir solunum desteğidir. Bu sistem; anatomik ölü boşluğu yıkayarak karbondioksiti temizler, pozitif nazofaringeal basınç oluşturarak alveollerin açık kalmasını sağlar ve mukosiliyer fonksiyonları koruyarak hasta konforunu artırır. Başlangıçta pediatride kullanılan bu yöntem, günümüzde özellikle COVID-19 ve akut hipoksemik solunum yetmezliği olan yetişkin hastaların yönetiminde popülerlik kazanmıştır. Yoğun bakımda, entübasyon ihtiyacını ve ventilatörde kalış süresini azaltma potansiyeline sahiptir. Ameliyathanelerde ise "THRIVE" adıyla, preoksijenasyon ve apneik oksijenasyon süreçlerinde, özellikle zor havayolu yönetiminde ve endoskopik işlemlerde güvenliği artırmak için kullanılır. Tedavinin başarısı ROX indeksi gibi araçlarla takip edilmelidir; zira entübasyonun 48 saatten fazla geciktirilmesi mortaliteyi artırabilmektedir. Nadiren burun rahatsızlığı gibi yan etkiler görülse de genel olarak iyi tolere edilir. Ancak kontrolsüz yüksek oksijen kullanımı (hiperoksi); atelektazi, doku hasarı ve vasküler komplikasyon risklerini de beraberinde getirmektedir.
High-Flow Nasal Cannula (HFNC) therapy is a non-invasive respiratory support system that delivers heated and humidified oxygen at high flow rates (20-60 L/min). The system functions by flushing anatomical dead space to clear carbon dioxide, creating positive nasopharyngeal pressure to keep alveoli open, and maintaining mucociliary function to enhance patient comfort. Initially used in pediatrics, this method has gained popularity in managing adults with COVID-19 and acute hypoxemic respiratory failure. In intensive care units, it has the potential to reduce the need for intubation and the duration of mechanical ventilation. In operating rooms, referred to as "THRIVE," it is used for preoxygenation and apneic oxygenation to improve safety during difficult airway management and endoscopic procedures. Treatment success should be monitored using tools like the ROX index, as delaying intubation beyond 48 hours can increase mortality. While minor side effects such as nasal discomfort may occur, it is generally well-tolerated. However, uncontrolled high oxygen levels (hyperoxia) carry risks of atelectasis, tissue damage, and vascular complications.
Referanslar
Sztrymf B, Messika J, Mayot T, et al. Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: A prospective observational study. J Crit Care 2012; 27: 9–13.
Brochard L, Slutsky A, Pesenti A. Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure. Am J Respir Crit Care Med 2017; 195: 438-42.
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2(7511):319-323.
Çiftçi, F. Yüksek Akımlı Oksijen Sistemleri. Güncel Göğüs Hastalıkları Serisi 6.2 (2018): 171-176.
Calvano TP, Sill JM, Kemp KR, Chung KK. Use of a high-flow oxygen delivery system in a critically ill patient with dementia. Respir Care 2008;53(12):1739-1743.
Carratala´ Perales JM, Llorens P, Brouzet B, Albert Jime´nez AR, Ferna´ndez-Can˜adas JM, Carbajosa Dalmau J, et al. High-flow therapy via nasal cannula in acute heart failure. Rev Esp Cardiol 2011; 64(8):723-725.
Frat JP, Ragot S, Girault C, Perbet S, Prat G, Boulain T, et al.; REVA network. Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post- hoc analysis of a randomised trial. Lancet Respir Med 2016;4(8):646-652.
Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al.; FLORALI Study Group, REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372(23):2185-2196.
Nishimura M. High-flow nasal cannula oxygen therapy in adults. J Intensive Care 2015; 3: 15.
Gürün Kaya A, Kaya A. Oksijen tedavisi, NIV, HFNC. Yamanel HL, editör. Yoğun Bakım ve COVID-19. 1. Baskı. Ankara: Türkiye Klinikleri, 2020. p.27-31.
Dalla Corte F, Ottaviani I, Montanari G, Wang YM, and Mauri T, (2021) Physiological Effects of High Flow in Adults, Annalisa Carlucci&Salvatore M. Maggiore (Eds), High Flow Nasal Cannula Physiological Efects and Clinical Applications (pp.55-67) Switzerland Springer
Sztrymf B, Messika J, Bertrand F, et al. Beneficial effects of humidified high flow nasal oxygen in critical care patients: A prospective pilot study. Intensive Care Med 2011; 37: 1780-6.
Bräunlich J, Beyer D, Mai D, et al. Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patient. Respiration 2013; 85: 319-25.
Spoletini G, Alotaibi M, Blasi F, Hill NS. Heated humidified highflow nasal oxygen in adults: mechanisms of action and clinical implications. Chest 2015;148(1):253-261.
Nagata K, Morimoto T, Fujimoto D, Otoshi T, Nakagawa A, Otsuka K, et al. Efficacy of high-flow nasal cannula therapy in acute hypoxemic respiratory failure: decreased use of mechanical ventilation. Respir Care 2015;60(10):1390-1396.
Parke R.L. (2016) High-Flow Nasal Cannula Oxygen in Acute Respiratory Failure After Extubation: Key Practical Topics and Clinical Implications. In: Esquinas A. (Eds) Noninvasive Mechanical Ventilation and Diffcult Weaning in Critical Care. Springer, Cham
Balkaya A. Yeni Teknolojik Gelişmeler Eşliğinde Mekanik Ventilatör Modları. Özlü C, Köylüoğlu N, Gedik MA, Yangal HS, Özlü A, editör. 1. Baskı. Ankara: Akademisyen Kitabevi; 2021.p 277-290
Ischaki E, Pantazopoulos I, Zakynthinos S. Nasal high fow therapy: a novel treatment rather than a more expensive oxygen device. Eur Respir Rev. 2017;26:170028.
Kang BJ, Koh Y, Lim CM, Huh JW, Baek S, Han M, et al. Failure of high-fow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med. 2015;41:623–32.
Koga Y, Kaneda K, Mizuguchi I, Nakahara T, Miyauchi T, Fujita M, et al. Extent of pleural effusion on chest radiograph is associated with failure of high-fow nasal cannula oxygen therapy. J Crit Care. 2016;32:165–9.
Messika J, Ben Ahmed K, Gaudry S, Miguel-Montanes R, Rafat C, Sztrymf B, et al. Use of high-fow nasal cannula oxygen therapy in subjects with ARDS: a 1-year observational study. Respir Care. 2015;60:162–9.
Rello J, Perez M, Roca O, Poulakou G, Souto J, Laborda C, et al. High-fow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 infuenza a/H1N1v. J Crit Care. 2012;27:434–9.
Frat JP, Brugiere B, Ragot S, Chatellier D, Veinstein A, Goudet V, et al. Sequential application of oxygen therapy via high-fow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study. Respir Care. 2015;60:170–8
Roca O, Messika J, Caralt B, Garcia-de-Acilu M, Sztrymf B, Ricard JD, et al. Predicting success of high-fow nasal cannula in pneumonia patients with hypoxemic respiratory failure: the utility of the ROX index. J Crit Care. 2016;35:200–5.
Brewster DJ, Chrimes N, Do TB, et al. Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group. Med J Aust 2020;212(10):472-81.
Li J, Fink JB, Ehrmann S. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J 2020;55(5).
Alhazzani W, Moller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020;46(5):854-87.
Harari SA, Vitacca M, Blasi F, et al. Managing the Respiratory care of patients with COVID-19. [Available from: http://www.aiponet.it :Italian Thoracic Society – Associazione ItalianaPneumologi Ospedalieri Societa Italiana Di Pneumologia;2020.
Nagata K, Kikuchi T, Horie T, Shiraki A, Kitajima T, Kadowaki T, et al. Domiciliary high-flow nasal cannula oxygen therapy for patients with stable Hypercapnic chronic obstructive pulmonary disease. A multicenter randomized crossover trial. Ann Am Thorac Soc. 2018;15:432–9.
Esquinas Rodriguez AM, Papadakos PJ, Carron M, Cosentini R, Chiumello D.Clinical review: Helmet and non-invasive mechanical ventilation in critically ill patients. Crit Care. 2013 Apr 25;17(2):223.
Ozyilmaz E, Ugurlu AO, Nava S. Timing of noninvasive ventilation failure: causes, risk factors, and potential remedies. BMC Pulm Med. 2014 Feb 13;14:19.
Monro-Somerville T, Sim M, Ruddy J, Vilas M, Gillies MA. The Effect of High-Flow Nasal Cannula Oxygen Therapy on Mortality and Intubation Rate in Acute Respiratory Failure: A Systematic Review and Meta-Analysis. Crit Care Med. 2017 ;45(4):e449-e456.
Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care med. 2020.
Maggiore SM, Idone FA, Vaschetto R, Festa R, Cataldo A, Antonicelli F, et al. Nasal high-flow versus Venturi mask oxygen therapy after extubation. Am J Respir Crit Care Med. 2014;190:282–8.
Miguel-Montanes R, Hajage D, Messika J, Bertrand F, Gaudry S, Rafat C, et al. Use of high-flow nasal cannula oxygen therapy to prevent desaturation during tracheal intubation of intensive care patients with mild-to-moderate hypoxemia. Crit Care Med. 2015;43:574–83.
Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke. A 10-year follow-up. Arch Intern Med. 2008;168(3):297–301.
McGinley BM, Patil SP, Kirkness JP, Smith PL, Schwartz AR, Schneider H. A nasal cannula can be used to treat obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176:194–200.
Haba-Rubio J, Andries D, Rey V, Michel P, Tafti M, Heinzer R. Effect of transnasal insufflation on sleep disordered breathing in acute stroke: preliminary study. Sleep Breath. 2012;16:759–64.
Masip J, Betbesé AJ, Páez J, Vecilla F, Cañizares R, Padró J, et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial. Lancet. 2000;356:2126–32.
Moriyama K, Satoh T, Motoyasu A, Kohyama T, Kotani M, Kanai R, et al. High-flow nasal cannula therapy in a patient with reperfusion pulmonary edema following percutaneous transluminal pulmonary angioplasty. Case Rep Pulmonol 2014. doi.org/1 k0.115/2014/837612.
Lucangelo U, Vassallo FG, Marras E, Ferluga M, Beziza E, Comuzzi L, et al. High-flow nasal interface improves oxygenation in patients undergoing bronchoscopy. Crit Care Res Pract. 2012;2012:506382. doi: 10.1155/2012/506382.
Peters SG, Holets SR, Gay PC. High-flow nasal cannula therapy in do-not intubate patients with hypoxemic respiratory distress. Respir Care. 2013;58(4):597–600.
De Jong A., Rolle A.,Ducros L.,Aarab Y., Monet C., Jaber S., (2021) Physiological Effects of High Flow in Adults, Annalisa Carlucci&Salvatore M. Maggiore (Eds), Clinical applications of High-Flow Nasal Cannula in the Operating Room.pp (101-108) Switzerland Springer
Patel A, Nouraei SA. Transnasal humidifed rapid-insuffation Ventilatory exchange (THRIVE): a physiological method of increasing apnoea time in patients with diffcult airways. Anaesthesia. 2015;70(3):323–9.
Booth AWG, Vidhani K, Lee PK, Thomsett CM. SponTaneous respiration using IntraVEnous anaesthesia and Hi-fow nasal oxygen (STRIVE Hi) maintains oxygenation and airway patency during management of the obstructed airway: an observational study. Br J Anaesth. 2017;118(3):444–51.
Badiger S, John M, Fearnley RA, Ahmad I. Optimizing oxygenation and intubation conditions during awake fbre-optic intubation using a high-fow nasal oxygen-delivery system. Br J Anaesth. 2015;115(4):629–32.
Heinrich SHT, Stubner B, et al. Benefts of heated and humidifed high fow nasal oxygen for preoxygenation in morbidly obese patients undergoing bariatric surgery: a randomised controlled study. J Obes Bariatrics. 2014;I(I):7–13.
Moller W, Feng S, Domanski U, Franke KJ, Celik G, Bartenstein P, et al. Nasal high fow reduces dead space. J Appl Physiol (1985). 2017;122(1):191–7.
Frerk C, Mitchell VS, McNarry AF, Mendonca C, Bhagrath R, Patel A, et al. Diffcult Airway Society 2015 guidelines for management of unanticipated diffcult intubation in adults. Br J Anaesth. 2015;115(6):827–48.
Ffrench-O'Carroll R, Fitzpatrick K, Jonker WR, Choo M, Tujjar O. Maintaining oxygenation with high-fow nasal cannula during emergent awake surgical tracheostomy. Br J Anaesth. 2017;118(6):954–5.
Jonker Y, Rutten DJ, van Exel ER, Stek ML, de Bruin PE, Huitink JM. Transnasal humidifed rapid-insuffation ventilatory exchange during electroconvulsive therapy: a feasibility study. J ECT. 2018;35:110.
Beers MF. Oxygen Therapy and Pulmonary Oxygen Toxicity. Fishman’s Pulmonary Diseases and Disorders. McGraw- Hill Companies; 2008; 149: 2613- 29. Sepehrvand N, Ezekowitz JA. Oxygen therapy in patients with acute heart failure: friend or foe? JACC Heart Fail. 2016;4(10):783–90.
McNulty PH, et al. Effects of supplemental oxygen administration on coronary blood fow in patients undergoing cardiac catheterization. Am J Physiol Heart Circ Physiol. 2005;288(3):H1057–62.
